Cleared Traditional

K770592 - CYTOLOGY FIXATIVE (FDA 510(k) Clearance)

Class I Pathology device.

K770592 · Surgipath Medical Industries, Inc. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1977
Decision
53d
Days
Class 1
Risk

K770592 is an FDA 510(k) clearance for the CYTOLOGY FIXATIVE. Classified as Preservative, Cytological (product code LEA), Class I - General Controls.

Submitted by Surgipath Medical Industries, Inc. (Mchenry, US). The FDA issued a Cleared decision on May 20, 1977 after a review of 53 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.4010 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Surgipath Medical Industries, Inc. devices

Submission Details

510(k) Number K770592 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 28, 1977
Decision Date May 20, 1977
Days to Decision 53 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 77d · This submission: 53d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LEA Preservative, Cytological
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.4010
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.